Clinical Development Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Clinical Development stocks.

Clinical Development Stocks Recent News

Date Stock Title
May 9 ONCT Oncternal Therapeutics, Inc. (ONCT) Q1 2024 Earnings Call Transcript
May 9 EQ Equillium GAAP EPS of -$0.08, revenue of $10.7M
May 9 EQ Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates
May 9 SVRA Savara GAAP EPS of -$0.11 misses by $0.01
May 9 ONCT Oncternal Therapeutics GAAP EPS of -$2.83 beats by $0.05, revenue of $0.57M beats by $0.44M
May 9 SVRA Savara Reports First Quarter 2024 Financial Results and Provides Business Update
May 9 EQ Equillium Reports First Quarter 2024 Financial Results and Provides Recent Clinical Highlights
May 9 ONCT Oncternal Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results
May 9 LXRX Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024
May 8 ONCT Oncternal Therapeutics Q1 2024 Earnings Preview
May 8 LIXT LIXTE Biotechnology Co-Sponsoring International Scientific Conference on “Therapeutic Over-Activation in Cancer”
May 8 FGEN FibroGen First Quarter 2024 Earnings: Beats Expectations
May 7 CPIX Cumberland Pharmaceuticals Non-GAAP EPS of -$0.05, revenue of $8.5M
May 7 SVRA Savara to Present at the Citizens JMP Life Sciences Conference
May 7 CPIX Cumberland Pharmaceuticals Reports First Quarter 2024 Financial Results & Company Update
May 7 FGEN FibroGen, Inc. (NASDAQ:FGEN) Q1 2024 Earnings Call Transcript
May 7 FGEN Q1 2024 FibroGen Inc Earnings Call
May 7 EQ Equillium Announces Poster Presentation at the Annual Meeting of The American Association of Immunologists
May 7 FGEN FibroGen to Participate in Upcoming Investor Conferences
May 7 SAGE Sage Therapeutics to Participate in Upcoming May Investor Conferences
Clinical Development

Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.

Browse All Tags